Search Results 401-410 of 17175 for egfr

  1. Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot - Mayo Clinic

    Severe renal dysfunction (Estimated Glomerular Filtration Rate (eGFR)< 30 ml/min/1.73m2); Requirement for inotropes (other than digoxin) or mechanical ...

  2. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

    - Estimated glomerular filtration rate (eGFR) >= 30 mL/min/1.73 m^2 (=< 28 days prior to registration) - As calculated by Modification of Diet in Renal ...

  3. Clinical Trials - Tesevatinib in Subjects With ADPKD

    eGFR ≥ 25 mL/min/1.73 m2 and ≤ 90 mL/min/1.73 m2, using the Modification of Diet in Renal Disease-4 variable formula. htTKV must meet the following ...

  4. Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells - Mayo Clinic

    ... (eGFR less that 45 mL/min) and therefore cannot have a CT examination; Individuals not eligible for MRI and have a prior significant reaction to intravenous ...

  5. Methadone versus Intrathecal Hydromorphone for Analgesia Patients Undergoing Surgery for Gynecologic Malignancy via Midline Laparotomy Receiving Liposomal Bupivacaine - Mayo Clinic

    * Chronic kidney disease with estimated glomerular filtration rate (eGFR) \< 30 milliliters per minute (mL/min) * Documented cirrhosis * Preoperative ...

  6. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

    Note: Evidence of EGFR expression in the tumor is not required. Note: Although testing for other RAS mutations is not required, a known mutation in other ...

  7. Early Feasibility Study of HyperQureTM RDN System, Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension - Mayo Clinic

    Individual has an eGFR of <60 mL/min/1.73m2, using the 4 variable Modification of Diet in Renal Disease (MDRD) calculation (in mL/min) per 1.73 m2 = 175 x ...

  8. SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients - Mayo Clinic

    14 days posttransplant eGFR > 10mL/min by the C-G equation; Able to ingest tablets. Exclusion Criteria: Multi organ transplant recipient; Plasma CMV PCR > LOD ...

  9. Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI - Mayo Clinic

    Epidermal growth factor receptor (eGFR) should be above 30 within 30 days the time of mpMRI. Participating Mayo Clinic locations. Study statuses change often ...

  10. Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    Estimated glomerular filtration rate (eGFR) ≥ 60 mL/min, as calculated by the Cockcroft-Gault equation; HbA1c ≤ 9.5%; Alanine aminotransferase (ALT) < 5 x ...